Oral anticoagulant therapy has a high risk-benefit profile and is labor intensive to manage. A better understanding of the indications for anticoagulation and of prothrombin time monitoring has led to improved outcomes. The development of anticoagulation management services has also improved the overall management of anticoagulation and the resulting clinical outcomes. By reducing adverse events, anticoagulation management services also result in more cost-effective therapy. Although these results have been generated by mostly nonrandomized observational studies, until better quality investigations are available, the preponderance of current clinical evidence strongly supports the value of a coordinated approach to care by an anticoagulation management service.